135 related articles for article (PubMed ID: 7577144)
1. [Kinetics of glucose metabolism in central neurocytomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Oct; 47(10):981-7. PubMed ID: 7577144
[TBL] [Abstract][Full Text] [Related]
2. [Hemocirculation and metabolism in intraventricular tumors: kinetic analysis of glucose metabolism].
Shioya H; Mineura K; Kowada M; Iida H; Murakami M; Ogawa T; Hatazawa J; Uemura K
No Shinkei Geka; 1996 Mar; 24(3):211-9. PubMed ID: 8851949
[TBL] [Abstract][Full Text] [Related]
3. Blood flow and metabolism of central neurocytoma: a positron emission tomography study.
Mineura K; Sasajima T; Itoh Y; Sasajima H; Kowada M; Tomura N; Uesaka Y; Ogawa T; Hatazawa J; Uemura K
Cancer; 1995 Oct; 76(7):1224-32. PubMed ID: 8630902
[TBL] [Abstract][Full Text] [Related]
4. [Longitudinal analysis of glucose metabolism in recurrent meningioma].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1994 Nov; 46(11):1088-93. PubMed ID: 7873283
[TBL] [Abstract][Full Text] [Related]
5. [Kinetic analysis of glucose metabolism in meningiomas--comparison with malignant gliomas].
Shioya H; Mineura K; Sasajima T; Kowada M; Iida H; Ogawa T; Hatazawa J; Uemura K
No To Shinkei; 1995 Jun; 47(6):549-56. PubMed ID: 7605682
[TBL] [Abstract][Full Text] [Related]
6. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
7. Subependymoma of the septum pellucidum: characterization by PET.
Mineura K; Shioya H; Kowada M; Ogawa T; Hatazawa J; Uemura K
J Neurooncol; 1997 Apr; 32(2):143-7. PubMed ID: 9120543
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
[TBL] [Abstract][Full Text] [Related]
9. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Tsuyuguchi N
Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
[TBL] [Abstract][Full Text] [Related]
11. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
Kuwabara H; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
[TBL] [Abstract][Full Text] [Related]
12. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
Jagust WJ; Seab JP; Huesman RH; Valk PE; Mathis CA; Reed BR; Coxson PG; Budinger TF
J Cereb Blood Flow Metab; 1991 Mar; 11(2):323-30. PubMed ID: 1997504
[TBL] [Abstract][Full Text] [Related]
13. Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: reduced capillary influx.
Cornford EM; Gee MN; Swartz BE; Mandelkern MA; Blahd WH; Landaw EM; Delgado-Escueta AV
Ann Neurol; 1998 Jun; 43(6):801-8. PubMed ID: 9629850
[TBL] [Abstract][Full Text] [Related]
14. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate.
Kuwabara H; Gjedde A
J Nucl Med; 1991 Apr; 32(4):692-8. PubMed ID: 2013809
[TBL] [Abstract][Full Text] [Related]
15. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
Torizuka T; Tamaki N; Inokuma T; Magata Y; Sasayama S; Yonekura Y; Tanaka A; Yamaoka Y; Yamamoto K; Konishi J
J Nucl Med; 1995 Oct; 36(10):1811-7. PubMed ID: 7562048
[TBL] [Abstract][Full Text] [Related]
16. Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease.
Piert M; Koeppe RA; Giordani B; Minoshima S; Kuhl DE
J Nucl Med; 1996 Jul; 37(7):1115-22. PubMed ID: 8965180
[TBL] [Abstract][Full Text] [Related]
17. Blood flow and metabolism of oligodendrogliomas: a positron emission tomography study with kinetic analysis of 18F-fluorodeoxyglucose.
Mineura K; Shioya H; Kowada M; Ogawa T; Hatazawa J; Uemura K
J Neurooncol; 1999 May; 43(1):49-57. PubMed ID: 10448871
[TBL] [Abstract][Full Text] [Related]
18. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
[TBL] [Abstract][Full Text] [Related]
19. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
Evans AC; Diksic M; Yamamoto YL; Kato A; Dagher A; Redies C; Hakim A
J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
[TBL] [Abstract][Full Text] [Related]
20. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
